The Biotechnology Innovation Organization (BIO), headquartered in the United States, is a leading advocate for the biotechnology industry, representing a diverse range of companies involved in biopharmaceuticals, agricultural biotechnology, and biofuels. Founded in 1993, BIO has played a pivotal role in shaping policies that foster innovation and growth within the sector. With a focus on advancing biotechnology research and development, BIO offers unique services such as networking opportunities, educational resources, and advocacy efforts that support its members. The organisation has achieved notable milestones, including hosting the world’s largest biotechnology conference, which attracts thousands of industry professionals annually. As a key player in the biotechnology landscape, BIO continues to drive advancements that enhance health, agriculture, and environmental sustainability.
How does Biotechnology Innovation Organization's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biotechnology Innovation Organization's score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
The Biotechnology Innovation Organization (BIO), headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the organisation. In the context of the biotechnology industry, organisations typically engage in various initiatives aimed at reducing their carbon footprint and addressing climate change. However, without specific commitments or data from BIO, it is unclear what measures they may be undertaking in this regard. As the industry evolves, it is essential for organisations like BIO to establish clear climate commitments and reduction targets to align with global sustainability goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biotechnology Innovation Organization has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
